MK-3866

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-3866, covering 2019-04-19 to 2019-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006) [Phase 1]